Literature DB >> 2723169

MR imaging of compressive myelomalacia.

W L Ramanauskas1, H I Wilner, J J Metes, A Lazo, J K Kelly.   

Abstract

The authors studied retrospectively 42 patients with the magnetic resonance (MR) diagnosis of myelomalacia. Depending on MR findings, the patients were grouped into early, intermediate, and late stages of myelomalacia. Early stage myelomalacia patients presented with high intensity signal changes on T2-weighted images involving the width of the affected cord. The intermediate stage patients were characterized by varying degrees of cystic necrosis of the central gray matter, better seen on T2-weighted images. Central cystic degeneration, syrinx formation, and atrophy were prominent features of the late stage of myelomalacia. Ten patients had follow-up MR examinations within 6 months of initial imaging. Two of the four early stage myelomalacia patients showed improvement in the repeat studies. The follow-up scans of the six intermediate and late stage myelomalacia patients showed either no change or progression of disease. Early stage myelomalacia may be reversible, depending on the severity of the initial spinal cord injury. Magnetic resonance can serve as a useful tool in the assessment and management of myelomalacia patients.

Entities:  

Mesh:

Year:  1989        PMID: 2723169     DOI: 10.1097/00004728-198905000-00005

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  26 in total

1.  Diffusion-weighted MRI of the cervical spinal cord using a single-shot fast spin-echo technique: findings in normal subjects and in myelomalacia.

Authors:  K Tsuchiya; S Katase; A Fujikawa; J Hachiya; H Kanazawa; K Yodo
Journal:  Neuroradiology       Date:  2003-01-15       Impact factor: 2.804

Review 2.  Cervical spondylotic amyotrophy.

Authors:  Sheng-Dan Jiang; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Eur Spine J       Date:  2010-08-08       Impact factor: 3.134

3.  Correlation between degree of subvoxel spinal cord compression measured with super-resolution tract density imaging and neurological impairment in cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Davis C Woodworth; Langston T Holly
Journal:  J Neurosurg Spine       Date:  2015-03-06

4.  Central spinal cord lesions in stenosis of the cervical canal.

Authors:  J H Faiss; G Schroth; W Grodd; E Koenig; B Will; A Thron
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

5.  The relevance of intramedullary high signal intensity and gadolinium (Gd-DTPA) enhancement to the clinical outcome in cervical compressive myelopathy.

Authors:  Yong Eun Cho; Jun Jae Shin; Keun Su Kim; Dong Kyu Chin; Sung Uk Kuh; Ji Hae Lee; Woo Ho Cho
Journal:  Eur Spine J       Date:  2011-07-22       Impact factor: 3.134

6.  Do intramedullary spinal cord changes in signal intensity on MRI affect surgical opportunity and approach for cervical myelopathy due to ossification of the posterior longitudinal ligament?

Authors:  Qizhi Sun; Hongwei Hu; Ying Zhang; Yang Li; Linwei Chen; Huajiang Chen; Wen Yuan
Journal:  Eur Spine J       Date:  2011-04-28       Impact factor: 3.134

7.  Prognostic factors that affect the surgical outcome of the laminoplasty in cervical spondylotic myelopathy.

Authors:  Jae-Sung Ahn; June-Kyu Lee; Bo-Kun Kim
Journal:  Clin Orthop Surg       Date:  2010-05-04

8.  Does increased signal intensity of the spinal cord on MR images due to cervical myelopathy predict prognosis?

Authors:  Y Morio; K Yamamoto; K Kuranobu; M Murata; K Tuda
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

Review 9.  Does the type of T2-weighted hyperintensity influence surgical outcome in patients with cervical spondylotic myelopathy? A review.

Authors:  Aditya Vedantam; Vedantam Rajshekhar
Journal:  Eur Spine J       Date:  2012-08-25       Impact factor: 3.134

10.  Age at Diagnosis and Baseline Myelomalacia Sign Predict Functional Outcome After Spinal Meningioma Surgery.

Authors:  Johannes Wach; Mohammed Banat; Patrick Schuss; Erdem Güresir; Hartmut Vatter; Jasmin Scorzin
Journal:  Front Surg       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.